Cortisol, a glucocorticoid that raises blood sugar and reduces insulin secretion (158), has been shown in a clinical study to increase insulin resistance in patients with T2D when the HPA axis loses its ability to lower cortisol levels during hyperglycemia (159). This evidence concerns the gene INS and Insulin resistance.